GovChime
IDVSmall business

BPA (single-award IDV) HT941023A0002PROGENICS PHARMACEUTICALS INC

Overview

Award facts

Obligated on orders under this IDV
$245.39K
$245,393 across 6 orders
Period of performance
From Feb 1, 2023
Modifications
1
Latest action Jan 7, 2025
Contract type
BPA (single-award IDV)
PIID HT941023A0002

Description of requirement

PYLARIFY (FLUORINE-18 PIFLUFOLASTAT) INJECTION

Dates and value

Award date
Signed on Jan 31, 2023
Ordering period ends
Jan 31, 2028
Ceiling
Ceiling (single-award vehicle): $1,000,000

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 1, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 7, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NamePROGENICS PHARMACEUTICALS INC
LocationNORTH BILLERICA, MA
UEIYLYKVRPCTCR3
CAGE code34KE9
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLANTHEUS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Defense Health Agency
  3. DEFENSE HEALTH AGENCY HCD WEST
Funded by
  1. Department of Defense
  2. Defense Health Agency
  3. NAV MED CTR SAN DIEGO CA - MM

Classification and competition

Classification

NAICS
325412PHARMACEUTICAL PREPARATION MANUFACTURING
Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Set-aside
Not reported
Contract pricing
Firm fixed priceJ

Solicitation and notices

Solicitation ID
HT941023N0007
Notices

Contract details

Cost Accounting Standards clause
Not applicable exempt from CASX
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Transaction history

Modification history

Base award
Jan 31, 2023
Latest action
Jan 7, 2025 — Supplemental agreement (within scope)Modification P00001
Latest substantive action
Jan 7, 2025 — Supplemental agreement (within scope)Modification P00001
Actions by type
  • Base award1
  • Supplemental agreement (within scope)1
2 actions recorded, Jan 31, 2023 to Jan 7, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Pricing and financing

Latest action: change in base and all options
$753,624

Socio-economic and policy

Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
BPAE
Multiple or single award
Single awardS
Awarding agency code
9700
Awarding sub-tier code
97DH
Contracting office code
HT9410
Transactions recorded under this award key
2

Funding

Funding agency code
9700
Funding sub-tier code
97DH
Funding office code
HT0500